Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients after Receiving Multimodality Treatment and Helical Tomotherapy
 
  • Details

Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients after Receiving Multimodality Treatment and Helical Tomotherapy

Journal
Anticancer Research
Journal Volume
39
Journal Issue
4
Pages
2207-2215
Date Issued
2019
Author(s)
Chen G.-Y.
CHIA-HSIEN CHENG  
YU-HSUAN CHEN  
MENG-YAO LU  
HSIU-HAO CHANG  
YUNG-LI YANG  
SHIANN-TANG JOU  
WEN-MING HSU  
SUNG-HSIN KUO  
DOI
10.21873/anticanres.13336
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064487425&doi=10.21873%2fanticanres.13336&partnerID=40&md5=9e22113c0202c29bc42d6824c4ba234f
https://scholars.lib.ntu.edu.tw/handle/123456789/469962
Abstract
Background/Aim: The local control and clinical outcome of pediatric patients with high-risk neuroblastoma treated with tomotherapy as part of a modern multimodality paradigm was assessed. Patients and Methods: Twenty-four high-risk neuroblastoma patients who received radiotherapy (RT) to the primary site using helical tomotherapy (median 21.6 Gy) were included. Local failure (LF) was correlated with biological and clinical prognostic factors. Event-free survival (EFS) and overall survival (OS) were estimated using Kaplan-Meier analysis. Results: After a median followup of 43.5 months, the 3-year cumulative incidence of LF, EFS, and OS were 21.1%, 45.8%, and 62.9%, respectively. Elevated serum lactate dehydrogenase ?1,500 U/l was associated with worse LF (p=0.02). There was no 3-year LF noted for patients with gross residual disease (GRD) who received more than 21.6 Gy. Conclusion: We demonstrated favorable local control of tomotherapy for the treatment of high-risk neuroblastoma. Dose escalation of RT for patients with GRD should be investigated. ? 2019 International Institute of Anticancer Research. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
lactate dehydrogenase; antineoplastic agent; lactate dehydrogenase; adolescent; Article; child; clinical article; clinical outcome; dermatitis; distant metastasis; event free survival; female; follow up; growth inhibition; high risk patient; histopathology; human; lactate dehydrogenase blood level; lymph node dissection; male; minimal residual disease; nausea and vomiting; neuroblastoma; neutropenia; overall survival; primary tumor; priority journal; radiation dose; thrombocytopenia; tomotherapy; treatment interruption; tumor recurrence; blood; hematopoietic stem cell transplantation; infant; intensity modulated radiation therapy; Kaplan Meier method; multimodality cancer therapy; neuroblastoma; preschool child; prognosis; risk; treatment outcome; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Neuroblastoma; Prognosis; Radiotherapy, Intensity-Modulated; Risk; Treatment Outcome
Publisher
International Institute of Anticancer Research
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science